stockrowDyne Therapeutics, Inc. (DYN) vs Viridian Therapeutics, Inc. (VRDN)
- Dyne Therapeutics, Inc. DYN 18.18 +4.72%
- Viridian Therapeutics, Inc. VRDN 28.83 +0.98%
Dyne Therapeutics, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.2B and $3.2B). Dyne Therapeutics, Inc. has the higher net margin (0.00% vs −1,724.1%) and the lower return on invested capital (−1,956.3% vs 0.00%). Across the 14 metrics below, Viridian Therapeutics, Inc. leads on 8 and Dyne Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | DYN | VRDN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (1,781.38%) | 0.00% |
| Net margin | 0.00% | (1,724.06%) | 0.00% |
| Free cash flow margin | 0.00% | (1,305.42%) | 0.00% |
| Return on equity | (81.57%) | 0.00% | (50.12%) |
| Return on assets | (60.29%) | (56.49%) | (45.60%) |
| Return on invested capital | (1,956.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack